Gene · 23345
Papers2,274
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,274
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma. | BMC Urol | 2023 | 37479989 | PubTator, text mining | PubMed |
| Building an Immune-Related Genes Model to Predict Treatment, Extracellular Matrix, and Prognosis of Head and Neck Squamous Cell Carcinoma. | Mediators Inflamm | 2023 | 37469759 | PubTator, text mining | PubMed |
| Comprehensive analysis of the role of a four-gene signature based on EMT in the prognosis, immunity, and treatment of lung squamous cell carcinoma. | Aging (Albany NY) | 2023 | 37462692 | PubTator, text mining | PubMed |
| Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients. | Eur J Med Res | 2023 | 37461056 | PubTator, text mining | PubMed |
| The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers. | Hum Genomics | 2023 | 37454130 | PubTator, text mining | PubMed |
| Genetic Screening of a Hungarian Cohort with Focal Dystonia Identified Several Novel Putative Pathogenic Gene Variants. | Int J Mol Sci | 2023 | 37445923 | PubTator, text mining | PubMed |
| TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia. | Mediterr J Hematol Infect Dis | 2023 | 37435040 | PubTator, text mining | PubMed |
| Engineering Robust Metallic Zero-Mode States in Olympicene Graphene Nanoribbons. | J Am Chem Soc | 2023 | 37428750 | PubTator, text mining | PubMed |
| Exploring the glycolytic cross-talk genes between inflammatory bowel disease and colorectal cancer. | Funct Integr Genomics | 2023 | 37428395 | PubTator, text mining | PubMed |
| Identification and validation of m6A-GPI signatures as a novel prognostic model for colorectal cancer. | Front Oncol | 2023 | 37427112 | PubTator, text mining | PubMed |
| Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning. | Front Pharmacol | 2023 | 37426809 | PubTator, text mining | PubMed |
| Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers. | Nat Commun | 2023 | 37419892 | PubTator, text mining | PubMed |
| Molecular insights into LINC complex architecture through the crystal structure of a luminal trimeric coiled-coil domain of SUN1. | Front Cell Dev Biol | 2023 | 37416798 | PubTator, text mining | PubMed |
| Research advances in drug therapy of endometriosis. | Front Pharmacol | 2023 | 37416064 | PubTator, text mining | PubMed |
| RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancer. | Front Oncol | 2023 | 37409251 | PubTator, text mining | PubMed |
| Novel potentially pathogenic variants detected in genes causing intellectual disability and epilepsy in Polish families. | Neurogenetics | 2023 | 37405542 | PubTator, text mining | PubMed |
| Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas. | Biomark Res | 2023 | 37403120 | PubTator, text mining | PubMed |
| Nuclear compression regulates YAP spatiotemporal fluctuations in living cells. | Proc Natl Acad Sci U S A | 2023 | 37399392 | PubTator, text mining | PubMed |
| Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer. | Front Oncol | 2023 | 37397364 | PubTator, text mining | PubMed |
| Tremulous spastic ataxia in a patient with a homozygous truncating SYNE1 variant. | Clin Park Relat Disord | 2023 | 37388713 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23345/papers?page=13